Deng Chaoqiang相关文献与解析，生知库 | 链接生命科学的每一步

Zhang, Yang; Fu, Fangqiu; Zhang, Qiao; Li, Lingling; Liu, Hui; Deng, Chaoqiang; Xue, Qianqian; Zhao, Yue; Sun, Wenrui; Han, Han; Gao, Zhendong; Guo, Chunmei; Zheng, Qiang; Hu, Hong; Sun, Yihua; Li, Yuan; Ding, Chen; Chen, Haiquan

肿瘤

肿瘤免疫

发表日期：2026

文献求助收藏

Proposal on incorporating consolidation-to-tumor ratio into the clinical T1 classification in patients with invasive lung adenocarcinoma

关于将实变与肿瘤比例纳入浸润性肺腺癌患者临床T1分期的提议

期刊:Translational Lung Cancer Research

影响因子:3.5

doi:10.21037/tlcr-2025-aw-1274

Zhang, Molin; Deng, Chaoqiang; Fu, Fangqiu; Ye, Ting; Turna, Akif; Li, Yuan; Zhang, Yang; Chen, Haiquan

Phase III Study of Mediastinal Lymph Node Dissection for Ground Glass Opacity-Dominant Lung Adenocarcinoma

纵隔淋巴结清扫术治疗磨玻璃影为主型肺腺癌的III期研究

期刊:Journal of Clinical Oncology

影响因子:41.9

doi:10.1200/JCO-25-00610

Zhang, Yang; Qian, Bin; Song, Qingping; Ma, Junjie; Cao, Hang; Deng, Chaoqiang; Wang, Shengping; Ye, Ting; Xiang, Jiaqing; Zhang, Yawei; Sun, Yihua; Yan, Yueren; Zheng, Shanbo; Wu, Haoxuan; Huang, Qingyuan; Hu, Hong; Li, Yuan; Fu, Fangqiu; Chen, Haiquan

Distinct survival, optimal combination strategy of immunotherapy, and immunophenotype in uncommon and 20ins EGFR-mut lung adenocarcinoma: a multi-center study

罕见和 20 例 EGFR 突变型肺腺癌患者的生存期差异、最佳免疫治疗联合策略和免疫表型：一项多中心研究

期刊:Molecular Biomedicine

影响因子:10.1

doi:10.1186/s43556-025-00331-1

Sun, Yiting; Xu, Lei; Deng, Chaoqiang; Du, Xinyang; Yu, Yongkui; Hao, Yuan; Wang, Huijuan; Wang, Xin; Zhang, Yang; Chen, Haiquan

Prediction of the pathological subtypes by intraoperative frozen section for patients with cT1N0M0 invasive lung adenocarcinoma (ECTOP-1015): a prospective multicenter study

术中冰冻切片预测cT1N0M0期浸润性肺腺癌患者的病理亚型（ECTOP-1015）：一项前瞻性多中心研究

期刊:International Journal of Surgery

影响因子:10.1

doi:10.1097/JS9.0000000000001667

Fu, Zichen; Shen, Xuxia; Deng, Chaoqiang; Cao, Hang; Jin, Yan; Zheng, Qiang; Yang, Yongguo; Qian, Bin; Yuan, Chunyan; Wang, Weihua; Zhang, Lei; Song, Qingping; Zuo, Shuying; Ma, Junjie; You, Shuqing; Zheng, Senzhong; Gao, Qingli; Su, Guangli; Zhang, Yang; Fu, Fangqiu; Chen, Haiquan; Li, Yuan

Resected lung adenocarcinoma with lymph node metastasis: is ground glass opacity component a prognostic factor?

肺腺癌切除伴淋巴结转移：磨玻璃影成分是预后因素吗？

期刊:Translational Lung Cancer Research

影响因子:3.5

doi:10.21037/tlcr-24-170

Deng, Chaoqiang; Jiang, Chenyu; Ma, Xiangyi; Fu, Fangqiu; Wang, Shengping; Li, Yuan; Zhang, Yang; Chen, Haiquan

The Overlooked Cornerstone in Precise Medicine: Personalized Postoperative Surveillance Plan for NSCLC

精准医疗中被忽视的基石：非小细胞肺癌的个性化术后监测方案

期刊:JTO Clinical and Research Reports

影响因子:3.5

doi:10.1016/j.jtocrr.2024.100701

Jiang, Chenyu; Zhang, Yang; Deng, Penghao; Lin, Han; Fu, Fangqiu; Deng, Chaoqiang; Chen, Haiquan

Systemic immune index predicts tumor-infiltrating lymphocyte intensity and immunotherapy response in small cell lung cancer.

系统免疫指数可预测小细胞肺癌中肿瘤浸润淋巴细胞强度和免疫治疗反应

期刊:Translational Lung Cancer Research

影响因子:3.5

doi:10.21037/tlcr-23-696

Deng Chaoqiang, Liao Jiatao, Fu Zichen, Fu Fangqiu, Li Di, Li Yuan, Wang Jialei, Chen Haiquan, Zhang Yang

Sublobar resection for adenocarcinoma in situ and minimally invasive adenocarcinoma diagnosed by intraoperative frozen section (ECTOP-1019): a study protocol of prospective, single-arm, multicenter, phase III study

肺亚叶切除术治疗原位腺癌和术中冰冻切片诊断的微浸润性腺癌（ECTOP-1019）：一项前瞻性、单臂、多中心III期研究方案

期刊:Journal of Thoracic Disease

影响因子:1.9

doi:10.21037/jtd-24-623

Zheng, Shanbo; Deng, Chaoqiang; Li, Yuan; Zhang, Yang; Chen, Haiquan

Protocol of a single-arm, multicenter, phase III trial for selective lymph node dissection in cT1N0M0 invasive non-small cell lung cancer with consolidation-tumor ratio >0.5 located in the apical segment: Eastern Cooperative Thoracic Oncology Projects ECTOP-1018 (SELLAS study)

针对位于肺尖段且实变肿瘤比 >0.5 的 cT1N0M0 浸润性非小细胞肺癌进行选择性淋巴结清扫的单臂、多中心 III 期试验方案：东部合作胸部肿瘤项目 ECTOP-1018（SELLAS 研究）

期刊:Journal of Thoracic Disease

影响因子:1.9

doi:10.21037/jtd-24-1114

Zhang, Yiliang; Deng, Chaoqiang; Luo, Xiaoyang; Yu, Yongfu; Zhang, Yang; Chen, Haiquan

Evolutionary proteogenomic landscape from pre-invasive to invasive lung adenocarcinoma

从癌前到癌变肺腺癌的进化蛋白质基因组图谱

Proposal on incorporating consolidation-to-tumor ratio into the clinical T1 classification in patients with invasive lung adenocarcinoma

关于将实变与肿瘤比例纳入浸润性肺腺癌患者临床T1分期的提议

Phase III Study of Mediastinal Lymph Node Dissection for Ground Glass Opacity-Dominant Lung Adenocarcinoma

纵隔淋巴结清扫术治疗磨玻璃影为主型肺腺癌的III期研究

Distinct survival, optimal combination strategy of immunotherapy, and immunophenotype in uncommon and 20ins EGFR-mut lung adenocarcinoma: a multi-center study

罕见和 20 例 EGFR 突变型肺腺癌患者的生存期差异、最佳免疫治疗联合策略和免疫表型：一项多中心研究

Prediction of the pathological subtypes by intraoperative frozen section for patients with cT1N0M0 invasive lung adenocarcinoma (ECTOP-1015): a prospective multicenter study

术中冰冻切片预测cT1N0M0期浸润性肺腺癌患者的病理亚型（ECTOP-1015）：一项前瞻性多中心研究

Resected lung adenocarcinoma with lymph node metastasis: is ground glass opacity component a prognostic factor?

肺腺癌切除伴淋巴结转移：磨玻璃影成分是预后因素吗？

The Overlooked Cornerstone in Precise Medicine: Personalized Postoperative Surveillance Plan for NSCLC

精准医疗中被忽视的基石：非小细胞肺癌的个性化术后监测方案

Systemic immune index predicts tumor-infiltrating lymphocyte intensity and immunotherapy response in small cell lung cancer.

系统免疫指数可预测小细胞肺癌中肿瘤浸润淋巴细胞强度和免疫治疗反应

Sublobar resection for adenocarcinoma in situ and minimally invasive adenocarcinoma diagnosed by intraoperative frozen section (ECTOP-1019): a study protocol of prospective, single-arm, multicenter, phase III study

肺亚叶切除术治疗原位腺癌和术中冰冻切片诊断的微浸润性腺癌（ECTOP-1019）：一项前瞻性、单臂、多中心III期研究方案

Protocol of a single-arm, multicenter, phase III trial for selective lymph node dissection in cT1N0M0 invasive non-small cell lung cancer with consolidation-tumor ratio >0.5 located in the apical segment: Eastern Cooperative Thoracic Oncology Projects ECTOP-1018 (SELLAS study)

针对位于肺尖段且实变肿瘤比 >0.5 的 cT1N0M0 浸润性非小细胞肺癌进行选择性淋巴结清扫的单臂、多中心 III 期试验方案：东部合作胸部肿瘤项目 ECTOP-1018（SELLAS 研究）